InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,253.43
(
-0.11%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119787
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Monday, 08/13/2007 8:43:39 AM

Monday, August 13, 2007 8:43:39 AM

Post# of 19309
Addressable Market for ATryn in DIC/Sepsis:

There are approximately 250,000 cases of DIC/sepsis annually in the US and a similar number in Europe (#msg-19928950).

(The number of cases in the US and Europe of severe sepsis per se, with or without DIC, is about 1.5 million annually: #msg-17411076.)

Considering the US market only (where GTC owns 100% of the commercial rights) and assuming a price per treatment of $10,000-$12,000, the addressable market size is (250K)x($10-12K) = $2.5-$3B (#msg-19928950, #msg-22015291).

GTC experts to be able to capture at least $1B of this market opportunity (#msg-19928950).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up